These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Lessons from a remarkable family with dopa-responsive dystonia. Harwood G; Hierons R; Fletcher NA; Marsden CD J Neurol Neurosurg Psychiatry; 1994 Apr; 57(4):460-3. PubMed ID: 8163996 [TBL] [Abstract][Full Text] [Related]
31. Open label evaluation of cannabidiol in dystonic movement disorders. Consroe P; Sandyk R; Snider SR Int J Neurosci; 1986 Nov; 30(4):277-82. PubMed ID: 3793381 [TBL] [Abstract][Full Text] [Related]
32. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Nygaard TG; Trugman JM; de Yebenes JG; Fahn S Neurology; 1990 Jan; 40(1):66-9. PubMed ID: 2296384 [TBL] [Abstract][Full Text] [Related]
33. Evidence for the role of spinal cord systems in Parkinson's disease-associated pain. Sage JI; Kortis HI; Sommer W Clin Neuropharmacol; 1990 Apr; 13(2):171-4. PubMed ID: 2328508 [TBL] [Abstract][Full Text] [Related]
36. Dystonia in Parkinson's disease. Tolosa E; Compta Y J Neurol; 2006 Dec; 253 Suppl 7():VII7-13. PubMed ID: 17131231 [TBL] [Abstract][Full Text] [Related]
37. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations. de la Fuente-Fernández R Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251 [TBL] [Abstract][Full Text] [Related]
39. CSF biopterin levels and clinical features of patients with juvenile parkinsonism. Furukawa Y; Nishi K; Kondo T; Mizuno Y; Narabayashi H Adv Neurol; 1993; 60():562-7. PubMed ID: 8420192 [No Abstract] [Full Text] [Related]
40. [A family of parkinsonism in which the clinical feature of constituents varied with the age of onset]. Sasaki R; Kuzuhara S; Taniguchi A; Narita Y; Naito Y Rinsho Shinkeigaku; 1994 Jul; 34(7):736-8. PubMed ID: 7955737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]